The demand to bring transformative therapeutics to patients and the escalating costs of doing so are driving the life science industry to seek collaborations with academia to stimulate innovation.

It is somewhat gratifying be able to state that the terminal nature of corporate employment has changed for a variety of reasons. 'Retrograde transition' to academia About a year and a half into ...